Selecta Biosciences, Inc. (SELB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1160433,
    "name": "Selecta Biosciences, Inc.",
    "stock_name": "Selecta Biosciences, Inc.",
    "full_name": "Selecta Biosciences, Inc.",
    "name_url": "stocks-analysis/selecta-biosciences-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "6.90",
    "chg": 0.19,
    "chgp": "2.83%",
    "dir": 1,
    "prev_price": "6.71",
    "mcapval": "277.32",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2320,
    "indexname": "S&P 500",
    "isin": "US8162121045",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "171.73 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/selecta-biosciences-inc-1160433-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Selecta Biosciences, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-selecta-biosciences-inc-technically-bullish-or-bearish-3546038",
        "imagepath": "",
        "date": "2025-09-20 19:23:37",
        "description": "As of 3 September 2025, the technical trend for Selecta Biosciences, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength, driven by daily moving averages indicating a bearish trend and a bearish outlook from the On-Balance Volume (OBV). While the weekly MACD and KST show mildly bullish signals, they are overshadowed by the overall bearish indicators across other time frames, including Bollinger Bands and Dow Theory. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -42.43% versus the S&P 500's 12.22%...."
      },
      {
        "title": "Is Selecta Biosciences, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-selecta-biosciences-inc-overvalued-or-undervalued-3542673",
        "imagepath": "",
        "date": "2025-09-20 17:59:05",
        "description": "As of 4 May 2023, Selecta Biosciences, Inc. has moved from a fair to a risky valuation grade. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -13.03, an EV to EBIT of -2.80, and an EV to EBITDA of -2.85. In comparison to peers, Selecta's P/E ratio stands at -6.4234, while Foghorn Therapeutics, Inc. has a P/E of -4.3113 and Invivyd, Inc. at -2.0534, indicating that Selecta is lagging behind its competitors in terms of valuation metrics.\n\nThe company's stock performance has been significantly underwhelming, with a year-to-date return of -42.43% compared to the S&P 500's positive return of 12.22% during the same period. This stark contrast reinforces the notion that Selecta Biosciences, Inc. is currently overvalued given its financial metrics and poor stock performance relative to the broader market...."
      }
    ],
    "total": 7,
    "sid": "1160433",
    "stock_news_url": "https://www.marketsmojo.com/news/selecta-biosciences-inc-1160433"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Selecta Biosciences, Inc. technically bullish or bearish?

2025-09-20 19:23:37

As of 3 September 2025, the technical trend for Selecta Biosciences, Inc. has changed from mildly bearish to bearish. The current technical stance is bearish with weak strength, driven by daily moving averages indicating a bearish trend and a bearish outlook from the On-Balance Volume (OBV). While the weekly MACD and KST show mildly bullish signals, they are overshadowed by the overall bearish indicators across other time frames, including Bollinger Bands and Dow Theory. The stock has underperformed significantly compared to the S&P 500, with a year-to-date return of -42.43% versus the S&P 500's 12.22%....

Is Selecta Biosciences, Inc. overvalued or undervalued?

2025-09-20 17:59:05

As of 4 May 2023, Selecta Biosciences, Inc. has moved from a fair to a risky valuation grade. The company appears to be overvalued based on its negative valuation ratios, including a Price to Book Value of -13.03, an EV to EBIT of -2.80, and an EV to EBITDA of -2.85. In comparison to peers, Selecta's P/E ratio stands at -6.4234, while Foghorn Therapeutics, Inc. has a P/E of -4.3113 and Invivyd, Inc. at -2.0534, indicating that Selecta is lagging behind its competitors in terms of valuation metrics. The company's stock performance has been significantly underwhelming, with a year-to-date return of -42.43% compared to the S&P 500's positive return of 12.22% during the same period. This stark contrast reinforces the notion that Selecta Biosciences, Inc. is currently overvalued given its financial metrics and poor stock performance relative to the broader market....

View All News